Why choose our Private Equity, Growth Equity and Venture Capital lawyers?
We are experts in our field, supported by our focus sector groups in technology, energy and natural resources, financial services and life sciences and by regulatory, commercial, IP and employment colleagues across our European network. Our lawyers specialise in fintech, healthtech and proptech, genomics and biopharma, food and beverage, ecommerce, data privacy, mobile payments and telecoms, among other specialisms. Our cross-practice teams help clients navigate complicated regulatory and commercial issues to get deals done.
Our teams act for disruptive companies, investment funds, management teams and debt providers operating in highly regulated sectors across Europe.
In the technology sector, we act across the TMT spectrum, including advising innovative data-led digital growth companies emerging from Europe's pre-eminent tech accelerators, on early stage rounds (including EIS and VCT) to later stage development capital including growth equity, venture debt, bridge financing and buy-outs/exits, whether via trade sale or IPO. In the life sciences sector our clients include IP-rich university spin-outs, mature biopharma and medical device companies and specialist life sciences funds.
Download: Fieldfisher Venture Capital Wrap 2021
Latest private equity and VC news and views
Sign up to our email digest